Publikationsserver
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia.
Chronic myeloid leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosine kinase. Imatinib mesylate (IM) is an inhibitor of BCR-ABL and has been approved for the treatment of CML. IM is well tolerated and highly efficacious as it induces stable long-t...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | |
| Format: | Dissertation |
| Jezik: | angleščina |
| Izdano: |
Philipps-Universität Marburg
2011
|
| Teme: | |
| Online dostop: | PDF-Volltext |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
No citations were found for this record.